Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.
Baselga J, Albanell J, Ruiz A, Lluch A, Gascón P, Guillém V, González S, Sauleda S, Marimón I, Tabernero JM, Koehler MT, Rojo F.
Baselga J, et al. Among authors: albanell j.
J Clin Oncol. 2005 Aug 10;23(23):5323-33. doi: 10.1200/JCO.2005.08.326. Epub 2005 Jun 6.
J Clin Oncol. 2005.
PMID: 15939921
Clinical Trial.